Helical is the virtual AI lab for pharma, designed to turn bio foundation models into reproducible discovery systems so every scientist can test hypotheses in-silico at the speed of inference. The platform has two product surfaces — the Virtual Lab for biologists and translational scientists, and the Model Factory for ML engineers and data scientists - built on the same data, the same models, and the same results. By putting both sides in the same system, Helical closes the gap between computational predictions and biological decision-making, so teams that traditionally worked in silos can collaborate on the same evidence.
Helical
- Life Sciences
- London, United Kingdom
- £7.5m
- helical.bio
- Update Information
More venture news
- 25 Jun 2026

RQ BioRQ Bio raises a £86m Series A led by Frazier Life Sciences to develop long-acting antibody protection against seasonal influenza
Series ALife Sciences - 23 Jun 2026

TRIMTECH TherapeuticsTRIMTECH Therapeutics lands an £11m seed extension led by JJDC and BGF to degrade toxic proteins linked to Alzheimer's and other neurodegenerative diseases
ExtensionLife Sciences - 19 Jun 2026

Houdini BioHoudini Bio launches with a £1.5m pre-seed led by SCVC to tackle gene silencing with machine learning DNA design platform
Pre-seedLife Sciences
